Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ARRAY BIOPHARMA INC Analyst Recommendations

  • Analyst Consensus: ARRY

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.091 Buy 11
    30 Days Ago 2.182 Buy 11
    60 Days Ago 1.545 Buy 11
    90 Days Ago 1.545 Buy 11
    120 Days Ago 1.545 Buy 11

  • Analyst Ratings: ARRY

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    UBS Neutral Buy 11/05/2009 —
    UBS Buy Neutral 09/08/2009 —
    Boenning & Scattergood Outperform Neutral 09/04/2009 —
    Robert W. Baird Outperform Neutral 09/04/2009 3.00
    Leerink Swann Outperform Mkt Perform 09/04/2009 2.00
    Boenning & Scattergood — Outperform 06/16/2009 6.00
    Rodman & Renshaw — Mkt Outperform 05/07/2008 15.00
    William Blair — Outperform 02/07/2008 —
    Collins Stewart — Buy 12/20/2007 16.00
    Morgan Joseph — Buy 12/04/2007 16.00
    Collins Stewart — Buy 11/07/2007 17.00
    Lehman Brothers — Overweight 10/09/2007 16.00
    Rodman & Renshaw — Mkt Outperform 08/13/2007 18.00
    JP Morgan — Overweight 05/23/2007 —
    Piper Jaffray — Outperform 01/04/2007 20.00
    Oppenheimer — Buy 12/15/2006 18.00
    CE Unterberg Towbin — Buy 12/06/2006 20.00
    WR Hambrecht — Buy 11/09/2006 17.00
    Banc of America Sec — Buy 11/02/2006 13.00
    Robert W. Baird — Outperform 10/26/2006 14.00
    Piper Jaffray — Outperform 08/08/2006 14.00
    Jefferies & Co — Buy 06/07/2006 17.00
    CE Unterberg Towbin — Buy 06/02/2006 14.00
    Merriman Curhan Ford — Buy 02/16/2006 —
    WR Hambrecht — Buy 09/07/2005 10.00
    UBS — Buy 02/17/2005 12.00
    Piper Jaffray — Outperform 01/04/2005 12.00
    AG Edwards — Buy 11/17/2004 11.00
    Fulcrum — Buy 09/21/2004 12.00
    Legg Mason — Buy 08/03/2004 15.00
    Next